CPX-351 TREATMENT OF PREVIOUSLY UNTREATED OLDER AML PATIENTS WITH HIGH RISK AML MARKEDLY INCREASES THE RESPONSE RATE OVER 7+3 IN PATIENTS WITH FLT3 MUTATIONS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Lancet, J; Uy, G; Cortes, J; Newell, L; Lin, T; Ritchie, E; Strickland, S; Stuart, R; Hogge, D; Solomon, S; Stone, R; Bixby, D; Kolitz, J; Schiller, G; Wieduwilt, M; Rao, A; Rubenstein, S; Stock, W; Foster, M; Erba, H; Goldberg, S; Powell, B; Podoltsev, N; Atallah, E; Warlick, E; Yee, K; Pagel, J; Norkin, M; Barta, S; Sandhu, I; Frankfurt, O; Gautier, M; Larson, M; Seiter, K; Levy, M; Bergeron, J; Berdeja, J; Kropf, P; Shemanski, L; Ryan, D; Chiarella, M; Paulsen, K; Louie, A; Medeiros, B

Published Date

  • June 1, 2016

Published In

Volume / Issue

  • 101 /

Start / End Page

  • 186 - 186

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0390-6078

Conference Name

  • 21st Congress of the European-Hematology-Association

Conference Location

  • Copenhagen, DENMARK

Conference Start Date

  • June 9, 2016

Conference End Date

  • June 12, 2016